7Ritchie CW, Chiu E, Harrigan S, et al. The Impact upon Extra-Pyramidal Side Effects,Clinical Symptoms and Quality of Life of a Switch from Conventional to Atypical Antipsychotics. in Elderly Patients with Schizophrenia [ J ]. Int J Geriatr Psychiatry,2003,18 ( 5 ) :432--440.
4C. Verstuyft,A. Robert,S. Morin,M. A. Loriot,A. Flahault,P. Beaune,C. Funck-Brentano,P. Jaillon,L. Becquemont. Genetic and environmental risk factors for oral anticoagulant overdose[J] 2003,European Journal of Clinical Pharmacology(11):739～745
5N. F. Wieringa,P. A. de Graeff,G. T. van der Werf,R. Vos. Cardiovascular drugs: discrepancies in demographics between pre- and post-registration use[J] 1999,European Journal of Clinical Pharmacology(7):537～544
6ECKHARDT K, LI S, AMMON S, et al. Same incidence of ad- verse drug events after codeine adminstration irrespective of the ge- netically determined differences in morphine formation[ J]. Pain, 1998, 76(1 -2) : 27 -33.
